Daily Archives: May 13, 2020
Interpreting a Covid-19 Test Result
13 May, 2020 | 02:18h | UTCPractice Pointer: Interpreting a covid-19 test result – The BMJ
Related: Interpreting Diagnostic Tests for SARS-CoV-2 – JAMA
Editorial: Waste in Covid-19 Research
13 May, 2020 | 02:17h | UTCWaste in covid-19 research – The BMJ
Related Landmark Paper from the Author: Avoidable waste in the production and reporting of research evidence – The Lancet (free registration required)
Related Commentary on Twitter
"A deluge of poor quality research is sabotaging an effective evidence based response" say @PaulGlasziou, Sharon Sanders and @Tammy_Hoffmann https://t.co/jvx8FQxQCo
— The BMJ (@bmj_latest) May 12, 2020
New Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19
13 May, 2020 | 02:14h | UTCSee also: Calculation Tool For Predicting Critical-ill COVID-19 At Admission
Related Preprint Study (just published): Development and validation of the COVID-19 severity index (CSI): a prognostic tool for early respiratory decompensation – medRxiv AND Calculation Tool: https://covidseverityindex.org/
Study: A Close Relative of SARS-CoV-2 Found in Bats Offers More Evidence It Evolved Naturally
13 May, 2020 | 02:08h | UTCA close relative of SARS-CoV-2 found in bats offers more evidence it evolved naturally – Cell Press
Original Article: A novel bat coronavirus closely related to SARS-CoV-2 contains natural insertions at the S1/S2 cleavage site of the spike protein – Current Biology
World Report: New Zealand Eliminates COVID-19
13 May, 2020 | 02:10h | UTCNew Zealand eliminates COVID-19 – The Lancet
See also: How New Zealand ‘eliminated’ Covid-19 after weeks of lockdown – CNN AND New Zealand has ‘effectively eliminated’ coronavirus. Here’s what they did right. – National Geographic AND Why New Zealand’s Coronavirus Elimination Strategy Is Unlikely to Work in Most Other Places – TIME
Study Commentary – Virus Wars: Return of Lopinavir/Ritonavir (Along with Ribavirin and Interferon)
13 May, 2020 | 02:12h | UTCVirus Wars: Return of Lopinavir/Ritonavir (along with ribavirin and interferon) – PulmCrit
Original Article: Triple Therapy Antiviral Combination Seems Promising for COVID-19 in Open-label, Randomized, Phase 2 Trial (study and commentaries)
Gastrointestinal, Hepatobiliary, and Pancreatic Manifestations of COVID-19
13 May, 2020 | 02:05h | UTC
Telepsychiatry and the Covid-19 Pandemic
13 May, 2020 | 02:02h | UTC
Updated WHO Guidance: Considerations for School-related Public Health Measures in the Context of COVID-19
13 May, 2020 | 01:57h | UTCRelated: Should Schools Reopen? Kids’ Role in Pandemic Still a Mystery (resources on the subject)
Hydroxychloroquine in Patients with COVID-19: A Systematic Review and Meta-analysis
13 May, 2020 | 01:53h | UTC“While initial studies with hydroxychloroquine showed some ray of hope, recent studies that have emerged found either no benefit or a possible harm in COVID-19.”
A Pandemic Benefit: The Expansion of Telemedicine
13 May, 2020 | 02:00h | UTCA Pandemic Benefit: The Expansion of Telemedicine – The New York Times
Related: COVID-19: Rapidly Converting to “Virtual Practices” (several commentaries on the subject) AND A digital embrace to blunt the curve of COVID19 pandemic – npj Digital Medicine
Allocating Scarce Resources and Triaging Patients during the COVID-19 Pandemic
13 May, 2020 | 01:55h | UTC
Remdesivir in COVID-19: A Critical Review of Pharmacology, Pre-clinical and Clinical Studies
13 May, 2020 | 01:50h | UTC“While the first double-blind, randomized-controlled trial (DBRCT) found no significant benefit with remdesivir compared to placebo, preliminary reports from another DBRCT showed a significant faster recovery, without any difference in mortality.”
Randomized Trial: Surgery vs. Functional Bracing in Patients with Closed Displaced Humeral Shaft Fractures
13 May, 2020 | 01:47h | UTCEffect of Surgery vs Functional Bracing on Functional Outcome Among Patients With Closed Displaced Humeral Shaft Fractures: The FISH Randomized Clinical Trial – JAMA (free for a limited period)
Commentaries: JAMA, the cozy new home for our FISH – Ficebo AND A Finnish study adds to knowledge about treating fractures of the humeral shaft – University of Helsinki
Related Commentary on Twitter
Our trial was just published in the prestigious JAMA. Happy days! @JAMA_current https://t.co/xpiTaZa3Yh
— Lasse Rämö (@lasseramo) May 12, 2020
The Dangers of Using Tumor Markers to Evaluate Nonspecific Symptoms
13 May, 2020 | 01:45h | UTCThe Dangers of Using Tumor Markers to Evaluate Nonspecific Symptoms: A Teachable Moment – JAMA Internal Medicine (free for a limited period)
The FDA has Authorized the use of Remdesivir: But There’s no Good Evidence it Reduces Mortality in Covid-19
13 May, 2020 | 01:49h | UTC
Randomized Trial: Acupuncture for Postprandial Distress Syndrome
13 May, 2020 | 01:42h | UTCCommentary: Acupuncture may offer some relief for postprandial distress syndrome, study finds – ACP Internist
Redefining Palliative Care – a New Consensus-based Definition
13 May, 2020 | 01:44h | UTC
Cohort Study: Association Between Tax on Sugar Sweetened Beverages and Soft Drink Consumption
13 May, 2020 | 01:38h | UTCCommentary: Mexico’s sugary drinks tax has helped cut consumption after just three years – The BMJ
Related: Meta-Analysis: Impact of Sugar‐sweetened Beverage Taxes on Purchases and Dietary Intake (free study and resources on the subject)
Wed May 13 – 10 Stories of The Day!
13 May, 2020 | 02:20h | UTC
1 – Practice Pointer: Interpreting a covid-19 test result – The BMJ
Related: Interpreting Diagnostic Tests for SARS-CoV-2 – JAMA
2 – Waste in covid-19 research – The BMJ
Related Landmark Paper from the Author: Avoidable waste in the production and reporting of research evidence – The Lancet (free registration required)
See also: Calculation Tool For Predicting Critical-ill COVID-19 At Admission
Related Preprint Study (just published): Development and validation of the COVID-19 severity index (CSI): a prognostic tool for early respiratory decompensation – medRxiv AND Calculation Tool: https://covidseverityindex.org/
4 – Virus Wars: Return of Lopinavir/Ritonavir (along with ribavirin and interferon) – PulmCrit
Original Article: Triple Therapy Antiviral Combination Seems Promising for COVID-19 in Open-label, Randomized, Phase 2 Trial (study and commentaries)
5 – New Zealand eliminates COVID-19 – The Lancet
See also: How New Zealand ‘eliminated’ Covid-19 after weeks of lockdown – CNN AND New Zealand has ‘effectively eliminated’ coronavirus. Here’s what they did right. – National Geographic AND Why New Zealand’s Coronavirus Elimination Strategy Is Unlikely to Work in Most Other Places – TIME
Original Article: A novel bat coronavirus closely related to SARS-CoV-2 contains natural insertions at the S1/S2 cleavage site of the spike protein – Current Biology
9 – A Pandemic Benefit: The Expansion of Telemedicine – The New York Times
Related: COVID-19: Rapidly Converting to “Virtual Practices” (several commentaries on the subject) AND A digital embrace to blunt the curve of COVID19 pandemic – npj Digital Medicine
10 – Coronavirus Disease (COVID-19) Updates / 13 May 2020 Edition
13 May 2020 Edition – COVID-19/SARS-CoV-2 Latest Articles, Guidelines, News & Perspectives (several free resources)